Dr Jennifer Moliterno is chief of neurosurgical oncology at Yale University, New Haven and clinical director the Chenevert Brain Tumour Centre. She is also the Director of the Multidisciplinary Brain Tumor Board and Precision Brain Tumor Board and the Director for the Neurosurgical Oncology Fellowship Program. She serves as Chair of the Lovemark Foundation Fund at Smilow Cancer Hospital, aimed at providing support for patients with brain tumors.
Her clinical expertise is in the surgical treatment of all types of primary brain tumors and skull base tumours. She performs the highest volume of brain tumor surgery in the state of Connecticut and routinely cares for patients seeking second or third opinions from afar. Dr. Moliterno has particular expertise in the treatment of complex brain tumors with the safe and effective use of more sophisticated microsurgical techniques, such as functional brain mapping and awake craniotomy.
Dr. Moliterno’s research interests parallel that of her clinical practice with a bench-to-bedside focus on the clinical implications of the genomics of brain tumors.She completed her internship and residency training in neurosurgery at Yale New Haven Hospital and clinical fellowship in neurosurgical oncology at the Memorial Sloan-Kettering Cancer Centre.